Dr. Rebecca Harrison, MD

Claim this profile

BC Cancer - The Vancouver Center

Studies Brain Tumor
Studies Central Nervous System Tumor
6 reported clinical trials
13 drugs studied

Area of expertise

1Brain Tumor
Rebecca Harrison, MD has run 5 trials for Brain Tumor. Some of their research focus areas include:
IDH positive
1p/19q co-deletion positive
H3 K27M positive
2Central Nervous System Tumor
Rebecca Harrison, MD has run 2 trials for Central Nervous System Tumor. Some of their research focus areas include:
IDH positive
1p/19q co-deletion positive
1p/19q loss positive

Affiliated Hospitals

Image of trial facility.
M D Anderson Cancer Center
Image of trial facility.
BC Cancer - The Vancouver Center

Clinical Trials Rebecca Harrison, MD is currently running

Image of trial facility.

ONC201

for Brain Tumor

This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically diagnosed H3 K27M-mutant diffuse glioma and have completed standard frontline radiotherapy.
Recruiting1 award Phase 3

More about Rebecca Harrison, MD

Clinical Trial Related7 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Rebecca Harrison, MD has experience with
  • ONC201
  • Survey Administration
  • Selinexor
  • Temozolomide (TMZ)
  • TTField
  • Carmustine
Breakdown of trials Rebecca Harrison, MD has run
Brain Tumor
Central Nervous System Tumor
Nervous System Tumor
Mesial Temporal Sclerosis
Solid Tumors

Other Doctors you might be interested in

Qian Lu, MDM D Anderson Cancer Center
Lois M RamondettaM D Anderson Cancer Center
Douglas Harrison, MDMD Anderson Cancer Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rebecca Harrison, MD specialize in?
Rebecca Harrison, MD focuses on Brain Tumor and Central Nervous System Tumor. In particular, much of their work with Brain Tumor has involved IDH positive patients, or patients who are 1p/19q co-deletion positive.
Is Rebecca Harrison, MD currently recruiting for clinical trials?
Yes, Rebecca Harrison, MD is currently recruiting for 1 clinical trial in Vancouver British Columbia. If you're interested in participating, you should apply.
Are there any treatments that Rebecca Harrison, MD has studied deeply?
Yes, Rebecca Harrison, MD has studied treatments such as ONC201, Survey Administration, Selinexor.
What is the best way to schedule an appointment with Rebecca Harrison, MD?
Apply for one of the trials that Rebecca Harrison, MD is conducting.
What is the office address of Rebecca Harrison, MD?
The office of Rebecca Harrison, MD is located at: BC Cancer - The Vancouver Center, Vancouver, British Columbia V5Z 4E6 Canada. This is the address for their practice at the BC Cancer - The Vancouver Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top